PIERRE, S.D. (AP) - South Dakota Attorney General Marty Jackley says South Dakota's share of a multi-state settlement with a drug company will exceed $2.5 million.
Officials have not yet determined what South Dakota will do with the money.
Janssen Pharmaceuticals Inc. and parent company Johnson and Johnson announced a $181 million settlement with 36 states over allegations it marketed anti-psychotic drugs for non-approved uses. The states alleged that Janssen promoted Risperdal, which is used to treat schizophrenia and other mental illnesses, for non-approved uses that include dementia, anger management and anxiety.
Jackley says marketing drugs for non-approved uses endangers consumers. He says the settlement serves notice that such practices will not be tolerated.
Janssen did not admit wrongdoing. But it agreed not to promote the drugs for off-label use or make misleading claims.